ロード中...

Adoptive immunotherapy against ovarian cancer

The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery and platinum-based chemotherapy. Nevertheless, the majority of patients experience disease recurrence. Although extensive efforts to find new therapeutic options, cancer cells invariably develop d...

詳細記述

保存先:
書誌詳細
出版年:J Ovarian Res
主要な著者: Mittica, Gloria, Capellero, Sonia, Genta, Sofia, Cagnazzo, Celeste, Aglietta, Massimo, Sangiolo, Dario, Valabrega, Giorgio
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869278/
https://ncbi.nlm.nih.gov/pubmed/27188274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-016-0236-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!